NEW YORK, April 5, 2017 /PRNewswire/ --
FinancialBuzz.com News Commentary
The legal cannabis marketis growing rapidly in the North America. According to Arcview Market Research, people in the United States and Canada spent an estimated $53.3
According to reports from Canadian national broadcaster, CBC News, the current Liberal government in Canada will announce legislation this month to legalize cannabis in Canada by July 1, 2018. The new law will allow adults with a minimum age of 18 to purchase cannabis and grow up to four cannabis plants per household. The report also said that the federal government will be in charge of licensing producers, while provincial governments will have the right to set price and manage distribution.
ChineseInvestors.com Inc. (OTCQB: CIIX) earlier today announced, "It will attend the 'Invest 2017' exhibition in Stuttgart, Germany which will take place from April 7th-8th, 2017. Invest 2017 is the leading trade fair and congress for finance and investment in Germany and provides CIIX the opportunity to introduce its media and nutritional hemp companies, http://www.ChineseFN.com and http://www.ChineseCBDoil.com to German investors.
Invest 2017 is considered to be the No. 1 meeting point for the finance and investment sector in Germany. As one of the largest financial sector events in Germany, it attracted more than 12,000 visitors and 144 exhibitors in 2016. Many private and institutional investors use the platform to obtain information, compare assets and invest while exhibitors have the opportunity to generate interest in raising investment capital for their ventures."
"I am delighted that CIIX is invited to attend 'Invest 2017' as an exhibitor. This exhibition provides CIIX a valuable opportunity to introduce our nutritional hemp business to the German financial sector and meet numerous potential investors," says Warren Wang, Founder and CEO of CIIX. He further added, "In March 2017, an act to legalize the use of cannabis for medicinal purposes was passed by the German parliament. The recent approval of medical cannabis will be good for the development of the hemp-based CBD market in Germany."
OWC Pharmaceutical Research Corporation (OTCQB: OWCP) is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments that target a variety of diseases and medical indications. The company works to bring patients better outcomes by identifying unique formulation and efficient delivery systems. The company offers Sublingual Soluble Tablets and Topical Creams. Its Tablets provide patients with an adequate alternative to smoking cannabis buds for the treatment and management of pain, and its Topical Cream treats various skin diseases, such as Psoriasis.
General Cannabis Corporation (OTCQB: CANN) is the all-in-one resource for the highest quality service providers available to the regulated cannabis industry. General Cannabis is a trusted partner to the cultivation, production and retail sides of the cannabis business through a combination of strong operating divisions such as security, marketing, operational consulting and products, real estate and financing. As a synergistic holding company, its divisions are able to leverage the strengths of each other, as well as a larger balance sheet, to succeed. Its subsidiaries include, Chiefton Design, GC Capital, Next Big Crop, Iron Protection Group, and Chiefton Supply Company.
United Cannabis Corporation (OTCQB: CNAB) provides consulting services, proprietary products and licenses its intellectual property to businesses in the cannabis industry. United Cannabis own distinct intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products. The Company's A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution designed to enable physicians and patients to implement and monitor effective therapy protocols. Prana Bio Nutrient Medicinals is a comprehensive full spectrum cannabinoid system that utilizes the entire cannabis plant by controlling specific cannabinoid ratios, accurate dosing, and multiple non-abrasive delivery methods.
Corbus Pharmaceuticals (NASDAQ: CRBP) is a clinical stage biopharmaceutical company focusing on rare, life-threatening, chronic inflammatory diseases. The company's pipeline drug, Anabasum (JBT-101 or Resunab), is a first in class, synthetic oral endocannabinoid-mimetic drug that preferentially binds to the CB2 receptor expressed on activated immune cells and fibroblasts. CB2 activation triggers endogenous pathways that resolve inflammation and halt fibrosis. Anabasum has the potential to be a safe and potent anti-inflammatory drug with a unique mechanism of action to treat a range of chronic inflammatory diseases. Anabasum is currently being evaluated for the treatment of cystic fibrosis, diffuse cutaneous systemic sclerosis ('systemic sclerosis'), dermatomyositis and systemic lupus erythematosus, four indications in which inflammation contribute to disease progression.
Please Sign Up Now at http://www.FinancialBuzz.com to receive alerts on trending financial news from all these companies. 'The Latest Buzz in Financial News'
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information: email@example.com +1-877-601-1879 Url: http://www.FinancialBuzz.com
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All